Use of the activated partial thromboplastin time for monitoring heparin therapy: problems and possible solutions.

L Poller, JM Thomson, DA Taberner

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)363-70
    JournalLa Ricerca in clinica e in laboratorio
    Volume19
    Issue number4
    Publication statusPublished - 1989

    Cite this